PDG13 CURRENT PRESCRIPTION PROFILE OF RIBAVIRIN FOR HEPATITIS C IN BRAZIL AND THE BUDGET IMPACT ANALYSIS ON UPDATED RECOMMENDATIONS FOR ITS USE BETWEEN 2020 AND 2024 IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Abstract
Authors
K. Tonini B. Pinheiro dos Santos T. Dahrug Barros M.L. Tonini G. Mosimann Jr. M. Araújo Guimarães Lemos J.N. Gomes S. Monzani Vivaldini N. Fernandes E.C. de Almeida G.F. Mendes Pereira